🕵️ Imunon, Inc. ($IMNN)
SEC insider & ownership activity, last 12 months · CIK 749647 · every row links its SEC filing
Over the last 12 months insiders sold $26K with no open-market buying against it. Eylward Susan sold $26K in discretionary trades (Jun–Jul). One red-flag 8-K in the window: Delisting notice (3.01), Aug 27, 2025.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
0 buyers, $0 (0 lots) · 1 seller, $26K (3 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Eylward Susan | 0 | – | 3 | $26K | Jul 20, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Armistice Capital, LLC | 10.0% | 13G | May 15, 2026 | filing ↗ | |
| Steven Boyd | 10.0% | 13G | May 15, 2026 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Officer/director changes (5.02) | Jun 29, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 29, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jun 16, 2026 | filing ↗ |
| Shareholder vote (5.07) | Jun 16, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 16, 2026 | filing ↗ |
| Material agreement (1.01) | Jun 1, 2026 | filing ↗ |
| New financial obligation (2.03) | Jun 1, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Jun 1, 2026 | filing ↗ |
| Charter/bylaw changes (5.03) | Jun 1, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jun 1, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 1, 2026 | filing ↗ |
| Earnings (2.02) | May 12, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 12, 2026 | filing ↗ |
| Officer/director changes (5.02) | May 1, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 1, 2026 | filing ↗ |
| Earnings (2.02) | Mar 31, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 31, 2026 | filing ↗ |
| Other events (8.01) | Mar 23, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 23, 2026 | filing ↗ |
| Officer/director changes (5.02) | Feb 2, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 2, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jan 7, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 7, 2026 | filing ↗ |
| Material agreement (1.01) | Dec 29, 2025 | filing ↗ |
| Other events (8.01) | Dec 29, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 29, 2025 | filing ↗ |
| Earnings (2.02) | Nov 13, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 13, 2025 | filing ↗ |
| Delisting notice (3.01) | Aug 27, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 27, 2025 | filing ↗ |